Sai Life Sciences Key Ratios
NSE: SAILIFE
₹1,473.60
As on 31-Aug-2026 10:54IST
Market cap
₹31,434 Cr
Revenue (TTM)
₹2,250 Cr
P/E Ratio
86.9
P/B Ratio
12.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -7.95 | 11.66 | 17.74 | 21.67 | 23.61 |
| EBIT | -22.23 | 22.66 | 36.01 | 85.12 | 38.09 |
| Net Profit | -29.55 | 21.22 | 50.65 | 226.89 | 41.69 |
| EPS | -29.86 | 19.09 | 43.61 | 354.66 | 36.27 |
| Book Value | -- | -- | 14.91 | 32.93 | 18.99 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 16.22 | 11.43 | 21.47 | 20.10 | 15.89 |
| Net Margin
| 10.74 | 6.45 | 15.77 | 15.39 | 9.83 |
| Return on equity
| 11.87 | 7.41 | 15.47 | 15.16 | 11.02 |
| Return on Capital
| 15.91 | 11.72 | -- | 20.97 | 15.53 |
| Return on Assets
| 6.84 | 4.14 | 10.66 | 10.09 | 6.17 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.04 | 0.06 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
20.97
|
15.53
|
12.03
|
6.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
15.47
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
15.47
|
15.16
|
11.02
|
8.99
|
1.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
10.66
--
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
10.66
|
10.09
|
6.17
|
3.69
|
0.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
21.47
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
21.47
|
20.10
|
15.89
|
11.45
|
5.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
15.77
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
15.77
|
15.39
|
9.83
|
5.54
|
0.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
23.50
|
18.20
|
13.78
|
8.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
17.74
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
17.74
|
29.38
|
15.66
|
20.38
|
39.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
36.01
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
36.01
|
63.66
|
60.56
|
141.42
|
100.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
50.65
--
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
50.65
|
105.08
|
105.45
|
729.00
|
60.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
43.61
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
43.61
|
101.82
|
74.12
|
2,574.71
|
-50.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
16.76
|
120.22
|
9.78
|
1.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
0.01
|
0.04
|
0.06
|
0.74
|
0.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
0.03
|
0.06
|
0.38
|
0.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.69
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
1.69
|
1.64
|
2.02
|
1.28
|
1.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.51
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
1.51
|
1.47
|
1.86
|
1.16
|
1.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
15.01
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
15.01
|
12.40
|
3.91
|
2.25
|
1.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
16.60
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
16.60
|
17.04
|
20.94
|
17.48
|
23.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.66
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
0.66
|
0.63
|
0.61
|
0.65
|
0.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
60.56
|
65.73
|
67.19
|
79.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
22.43
|
22.19
|
28.23
|
39.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
194.31
|
180.62
|
142.25
|
176.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
-111.32
|
-92.70
|
-46.83
|
-57.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
86.90
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
86.90
|
58.91
|
93.36
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
12.31
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
12.31
|
8.29
|
7.48
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
44.82
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
44.82
|
30.12
|
34.97
|
1.80
|
3.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
31,434
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sai Life Sciences
|
31,434
|
20,554
|
15,883
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|